Multiple Sclerosis TopicsShow More
Nurse practitioner Maria Milazzo has spent her life caring for children with pediatric multiple sclerosis, a condition that's only beginning to be understood. But from where she stands? The future is bright.
The great news about multiple sclerosis treatments? You’ve got options! The potentially stressful news? You’ve got A LOT of options. We break down the basics.
Learning you have secondary progressive multiple sclerosis can take a serious emotional toll. We asked a psychologist to share his best advice for how to get through.
The good news about treatments for multiple sclerosis? There are more than ever before! The challenge? There are more than ever before! Your introduction starts here.
The FDA recently approved two new drugs that give people with active secondary progressive multiple sclerosis more treatment choices than ever.
The new medications, siponimod (Mayzent, Novartis) and cladribine (Mavenclad, EMD Serono), bring treatment options to active secondary progressive multiple sclerosis (SPMS). Most treatments approved for MS are for relapsing, rather than progressive, forms of the disease.
Multiple sclerosis treatment is one of the fastest moving areas of medicine.
Patients living with multiple sclerosis (MS) in the US may try these disease-modifying therapies (DMTs) to slow down the long-term progression of the disease.
Several medications used for MS are injectable drugs — aka, shots. We’ve been running from shots since we were kids, but they don’t have to hurt as badly as we remember. Here are some simple tips to minimize the pain, while maximizing the treatment.
Lisa Emrich features favorite MS articles of 2018 in this comprehensive list.